Abstract

Early life stress has been linked to increased methylation of the Nuclear Receptor Subfamily 3 Group C Member 1 (NR3C1) gene, which codes for the glucocorticoid receptor. Moreover, early life stress has been associated with substance use initiation at a younger age, a risk factor for developing substance use disorders. However, no studies to date have investigated whether NR3C1 methylation can predict substance use in young individuals. This study included adolescents 13–14 years of age that reported no history of substance use at baseline, (N = 1041; males = 46%). Participants contributed saliva DNA samples and were followed in middle adolescence as part of KUPOL, a prospective cohort study of 7th-grade students in Sweden. Outcome variables were self-reports of (i) recent use, (ii) lifetime use, and (iii) use duration of (a) alcohol, (b) tobacco products, (c) cannabis, or (d) any substance. Outcomes were measured annually for three consecutive years. The predictor variable was DNA methylation at the exon 1 F locus of NR3C1. Risk and rate ratios were calculated as measures of association, with or without adjustment for internalizing symptoms and parental psychiatric disorders. For a subset of individuals (N = 320), there were also morning and afternoon salivary cortisol measurements available that were analyzed in relation to NR3C1 methylation levels. Baseline NR3C1 hypermethylation associated with future self-reports of recent use and use duration of any substance, before and after adjustment for potential confounders. The overall estimates were attenuated when considering lifetime use. Sex-stratified analyses revealed the strongest association for cigarette use in males. Cortisol analyses revealed associations between NR3C1 methylation and morning cortisol levels. Findings from this study suggest that saliva NR3C1 hypermethylation can predict substance use in middle adolescence. Additional longitudinal studies are warranted to confirm these findings.

Details

Title
DNA methylation of the glucocorticoid receptor gene predicts substance use in adolescence: longitudinal data from over 1000 young individuals
Author
Raffetti Elena 1   VIAFID ORCID Logo  ; Melas, Philippe Anastasios 2   VIAFID ORCID Logo  ; Landgren, Anton Jonatan 3   VIAFID ORCID Logo  ; Andersson Filip 4 ; Forsell, Yvonne 4 ; Lavebratt Catharina 5   VIAFID ORCID Logo  ; Galanti, Maria Rosaria 4   VIAFID ORCID Logo 

 Karolinska Institutet, Department of Global Public Health, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626) 
 Karolinska Institutet & Stockholm Health Care Services, Center for Psychiatry Research, Department of Clinical Neuroscience, Stockholm, Sweden (GRID:grid.467087.a) (ISNI:0000 0004 0442 1056); Karolinska University Hospital, Center for Molecular Medicine, Stockholm, Sweden (GRID:grid.24381.3c) (ISNI:0000 0000 9241 5705) 
 Research and Development Primary Health Care, Region Västra Götaland, Gothenburg, Sweden (GRID:grid.24381.3c); University of Gothenburg, Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, Gothenburg, Sweden (GRID:grid.8761.8) (ISNI:0000 0000 9919 9582) 
 Karolinska Institutet, Department of Global Public Health, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Stockholm Health Care District, Stockholm Region, Centre for Epidemiology and Community Medicine, Stockholm, Sweden (GRID:grid.4714.6) 
 Karolinska University Hospital, Center for Molecular Medicine, Stockholm, Sweden (GRID:grid.24381.3c) (ISNI:0000 0000 9241 5705); Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
21583188
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2572728710
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.